OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 87 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,905,095 | +54.3% | 559,117 | +12.8% | 0.00% | – |
| Q2 2023 | $4,476,171 | +964.5% | 495,700 | +309.1% | 0.00% | – |
| Q1 2023 | $420,498 | -21.3% | 121,181 | -44.5% | 0.00% | – |
| Q4 2022 | $534,496 | +93.0% | 218,162 | +117.1% | 0.00% | – |
| Q3 2022 | $277,000 | -32.3% | 100,481 | 0.0% | 0.00% | – |
| Q2 2022 | $409,000 | -79.1% | 100,481 | -78.1% | 0.00% | – |
| Q1 2022 | $1,958,000 | -50.2% | 459,553 | +9.4% | 0.00% | – |
| Q4 2021 | $3,931,000 | -63.0% | 420,031 | +8.9% | 0.00% | -100.0% |
| Q3 2021 | $10,633,000 | +86.0% | 385,830 | +88.8% | 0.00% | – |
| Q2 2021 | $5,718,000 | -0.9% | 204,356 | +17.6% | 0.00% | – |
| Q1 2021 | $5,768,000 | – | 173,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |